GlassScriptPhysician profile
Heidi Papesh
NPI 1467989343
$9,438.91
in general payments reported to CMS, 2019-2025
45 companies · $2,649 in 2025
The $2,649 reported for 2025 was more than what 96% of Gerontology (Nurse Practitioner) providers received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,355 · 2022: $599 · 2023: $2,255 · 2024: $2,580 · 2025: $2,649.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,484.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,484.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $1,002.28 | 2023-2025 | Mounjaro, Zepbound, Kisunla |
| Bayer Healthcare Pharmaceuticals INC. | $553.98 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $481.57 | 2021-2025 | Airsupra |
| Eisai INC. | $447.71 | 2023-2025 | |
| Abbvie INC. | $430.69 | 2022-2023 | |
| Neurocrine Biosciences, INC. | $410.84 | 2023-2025 | Ingrezza |
| Alnylam Pharmaceuticals INC. | $368.83 | 2023-2025 | Amvuttra, Onpattro |
| Novo Nordisk INC | $362.82 | 2021-2025 | Ozempic |
| Otsuka America Pharmaceutical, INC. | $349.91 | 2023-2025 | Rexulti |
| Abbott Laboratories | $304.03 | 2024-2025 | Freestyle Libre 3 |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $249.89 | 2025 | Caplyta |
| Sanofi-Aventis U.S. LLC | $242.71 | 2021-2025 | |
| Boston Scientific Corporation | $239.78 | 2023-2025 | Watchman Flx, Axonics |
| Teva Pharmaceuticals USA, INC. | $238.38 | 2021 | |
| Medtronic, INC. | $230.18 | 2023-2024 | Intellis Adaptivestim, Venaseal, Arctic Front Advance |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $214.56 | 2021-2024 | Repatha |
| Corcept Therapeutics | $212.48 | 2024-2025 | Korlym |
| Otsuka Pharmaceutical Development & Commercialization, INC. | $177.26 | 2021 | |
| Insmed, INC. | $169.57 | 2024-2025 | Arikayce |
| Inspire Medical Systems, INC. | $158.40 | 2023 | Inspire |
| Madrigal Pharmaceuticals | $140.42 | 2025 | Rezdiffra |
| Paratek Pharmaceuticals, INC. | $125.00 | 2023 | Nuzyra |
| Merck Sharp & Dohme LLC | $124.99 | 2023 | Verquvo |
| Glaxosmithkline, LLC. | $124.99 | 2024 | Arexvy |
| Urovant Sciences INC | $123.92 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $123.71 | 2024 | Uptravi, Opsumit |
| Axsome Therapeutics, INC. | $122.04 | 2025 | Auvelity |
| Tris Pharma INC | $121.66 | 2023 | Quillichew Er, Quillivant, Dyanavel Xr |
| Intuitive Surgical, INC. | $120.05 | 2024 | |
| Genzyme Corporation | $117.99 | 2023 | |
| Melinta Therapeutics, LLC | $116.90 | 2023 | Kimyrsa |
| Exact Sciences Corporation | $116.64 | 2025 | Cologuard Collection Kit |
| Incyte Corporation | $104.19 | 2021 | |
| Biomerieux INC | $103.00 | 2025 | Filmarray |
| Dexcom, INC. | $99.87 | 2025 | Dexcom Stelo Glucose Biosensor, Dexcom G7 Gss (161) |
| Pfizer INC. | $99.63 | 2025 | |
| Silk Road Medical, INC. | $94.50 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Teleflex LLC | $91.90 | 2023 | Urolift |
| United Therapeutics Corporation | $85.60 | 2025 | |
| Nevro Corp. | $84.51 | 2023 | Senza |
| Xeris Pharmaceuticals, INC. | $83.62 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $83.06 | 2022 | |
| Radius Health, INC. | $80.58 | 2025 | Tymlos |
| Tandem Diabetes Care, INC. | $61.16 | 2023 | T:Slim X2 Insulin Pump With Control-Iq |
| Biogen, INC. | $43.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Heidi Papesh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.